March 2020

Physician Education Express: INSPECT

Providers must review the INSPECT report for each patient during every visit prior to prescribing an opioid or benzodiazepine. The provider is responsible to document in the patient chart that the INSPECT report was reviewed.  The auto text “=inspect” can be utilized for more simplified documentation. The INSPECT report can be found in Cerner in the menu to the left of the screen.  During Cerner downtime the INSPECT report must be reviewed via the state website, or login at

To view the Physician Education Express go to

CLARIFICATION:  Providers do not need to query for every patient/each visit unless you are prescribing an opioid or benzodiazepine.  Please note revisions in the Physician Education Express stating "Providers must review the INSPECT report for each patient during every visit prior to prescribing an opioid or benzodiazepine."

Physician Education Express: BD PosiFlushâ„¢ Syringe Guide

Providers are reporting issues using the BD PosiFlush™ Syringes accurately. BD PosiFlush syringes require its seal to be broken prior to use.  To view the recent Physician Education Express with guidelines from BD on the proper use go to 

Physician Education Express: i-STAT Changes and Recalls

On January 15, 2020, the sole source vendor for our i-STAT Point of Care (POC) testing system announced the conclusion
of an FDA evaluation, in which it was determined that three i-STAT "test modules" or cartridges (namely the CHEM8+,
CG4+, and G3+ cartridges) have lost FDA clearance due to an unapproved change in their design a several years ago.
As a result, the Lab's accrediting agency, the College of American Pathologists (CAP) has informed the lab on 01/15/2020
that the Clinical Laboratory Improvement Amendments (CLIA) regulated complexity of these cartridges has changed.

These are now deemed high complexity Laboratory Developed Tests (LDTs); and have more stringent compliance

We are NOT pursuing the continued use of these cartridges as High Complexity LDTs due to the stringent regulations and
educational requirements for testing personnel that would take effect.

The system’s goal is to transition to alternate iSTAT cartridges where possible and move testing to the nearest IUH
laboratory where possible.

How this Affects IU Health:

  • Point of Care lactates (currently on CG4+) will be discontinued and moved to a platform in the local laboratory
  • G3+/CG4+ cartridges will transition to CG8+ for blood gas
  • CHEM8+ cartridges will transition to EC8+ & Crea cartridges as applicable (CG8+ where indicated for iCa)


To view the full Physician Education Express go to

Mitigating Burnout & Strengthening Engagement in Preceptorship Learning Event

World Hearing Date - March 3rd

Don't let hearing loss limit you

On World Hearing Day 2020, WHO will highlight that timely and effective interventions can ensure that people with hearing loss are able to achieve their full potential. It will draw attention to the options available in this respect.

Key messages for World Hearing Day 2020:

  • At all life stages, communication and good hearing health connect us to each other, our communities, and the world.
  • For those who have hearing loss, appropriate and timely interventions can facilitate access to education, employment and communication.
  • Globally, there is lack of access to interventions to address hearing loss, such as hearing aids.
  • Early intervention should be made available through the health systems


For more information and resources for reducing risk factors for hearing loss go to:

Indiana Hospital Association (IHA) Resources and Updates: Novel Coronavirus (2019-nCoV) and Influenza

The IHA team is working closely with the Indiana State Department of Health (ISDH) to assist with communications surrounding influenza activity and the Novel Coronavirus. According to the most recent Influenza-like Illness (ILI) report, activity is high and widespread across Indiana. Weekly updates are available from ISDH activity reports while national activity can be retrieved here. Ongoing evaluation and investigation to learn more about the Novel Coronavirus (2019-nCoV).

Protective and preventative measures remain essential in the prevention and containment of these conditions.  

Misconceptions and Facts about ASD Hands in Autism Handout

There are many misconceptions about individuals with autism spectrum disorder (ASD). Some examples of these misconceptions involve individuals believing:

  • There is a cure for ASD
  • ASD is an emotional problem
  • ASD occurs more often in families of high income/higher levels of education
  • All children with ASD have savant abilities in specific areas
  • Individuals with ASD do not become attached or show affection
  • ASD equally affects boys and girls

Check out the Hands in Autism Misconceptions and Facts about Autism Spectrum Disorder handout for more information about truths and misconceptions of ASD. 

For questions or to access additional resources for your families and caregivers, check out the HANDS in Autism® website or email


Indiana Interagency Autism Coordinating Council (IIACC) 2020 Quarterly Advisory Meeting Calendar

Building upon 6 years of systematic implementation efforts, the Indiana Interagency Autism Coordinating Council (IIACC) is a public council with many opportunities to engage whether you are an individual with ASD, family member, caregiver, LCC member, professional, advocacy group, skills provider in the areas of education, justice, behavioral and mental health, or medical health, or community stakeholder. The primary purpose of the IIACC is to facilitate engagement in efficient and effective exchange of information on autism-related activities and provide input to the State on important issues surrounding autism spectrum disorder (ASD). 

Quarterly advisory meeting, facilitated by HANDS in Autism®, are open to the public with upcoming 2020 meetings scheduled for March 5, July 2, September 3 and Dec 3, from 9:00am – 11:30am. Meetings are held at the Indiana Government Center in Indianapolis, Indiana. If you are interested in attending, please contact

For additional information about the IIACC, visit

Implanted Port Access

This module demonstrates how to utilize a sterile dressing, and access supplies, to access an implanted port correctly without contamination.


To access this module go to

Risky Business Newsletter: Taking the Risk Out of Central Line Removals

Patient safety and protecting patient privacy is an organizational priority. However, unintended events do still occur. Recently, there have been two incidents involving air embolisms during central line removals. While this may seem like a simple procedure, there is high risk for air embolism. Learn more about it in this month's issue of Risky Business 

CDC Train: Stop the Clot - What Every Healthcare Professional Should Know

This self-paced, online course for healthcare professionals provides the most current foundational information and clinical considerations to assess and treat patients with blood clots and clotting disorders, or those at risk of blood clots, to improve the ability of healthcare professionals to manage these patients.

Accreditation Statements and Continuing Education Information

CE Course Number: WB4010 CE Expiration Date: October 10, 2020

Continuing Medical Education for Physicians (CME): The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this Web Based activity for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CLICK HERE to register.

CDC Train: Respond to Disasters

To aid in effective planning for disasters, NCEH has developed multiple eLearning courses that highlight the public health-related effects of disasters. 

The course is made up of 4 related modules: (1) Public Health Impacts of Disasters, (2) Public Health Emergency Management, (3) Community Assessment for Public Health Emergency Response (CASPER), and (4) Disaster Surveillance.

These modules are designed to help the public health and emergency workforce better prepare for and respond to disasters. You may take each in order, or separately as needed.

CLICK HERE for more information or to register.

Pediatric Epilepsy Surgery Symposium


WHEN:  Saturday, March 7th from 8:00am - 2:30pm

WHERE:  Riley Outpatient Center - Ruth Lilly Auditorium

              575 Hospital Drive

              Indianapolis, IN 46202



The surgical epilepsy symposium is a regional event featuring lectures describing the resources and treatment option within the Riley Hospital for Children Surgical Epilepsy Program. Many patients with refractory seizures are referred either too late or to other epilepsy centers outside of Indiana; this opposes the mission of our program and Riley Hospital for Children. The targeted audience demographic includes patient caregivers and local caregivers including primary care doctors, community neurologists, and advanced practice providers.


At the conclusion of this activity, participants should be able to: 

  1. Identify when to refer a pediatric patient for a comprehensive evaluation for epilepsy surgery and what to expect following the referral.
  2. Describe the components of a comprehensive seizure surgery evaluation
  3. Describe cutting-edge technologies available for treating patients with medically refractory epilepsy
  4. Describe the surgically treatable epilepsies in children and the types of surgeries and outcomes following epilepsy surgery


Registration fee includes access to on-line conference materials, continental breakfast, break refreshments, and lunch.

$50 Healthcare Professionals
$25 IU School of Medicine and IU Health employees

After March 5, 2020, please register at the door.  All registration fees refunded if cancellations made before March 2, 2020.

Location and Parking

The symposium will be held in the Riley Outpatient Center-Ruth Lilly Auditorium located at 575 Riley Hospital Drive; Indianapolis, IN 46202. Parking is available in the Riley Outpatient Center Garage located south of the Riley Outpatient Center.


This activity has been approved for AMA PRA Category 1 Credit(s) ™ and ANCC contact hours by Indiana University School of Medicine.

In support of improving patient care, Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Indiana University School of Medicine designates this activity for a maximum of 5.0 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Indiana University School of Medicine designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.

For more information and to register visit: 



Clinical Medical Ethics Fellowship Lunch & Learn

March is Amyloidosis Awareness Month

Did you know that March is Amyloidosis month? Amyloidosis is a disorder in which misfolded native proteins deposit extracellularly and lead to organ damage. Although the various types of amyloidoses share in common the deposition of misfolded proteins that aggregate as fibrils in tissue, they differ in actual protein composition, organ involvement, prognostic implication and most importantly, treatment. It is therefore critically important to determine the type of amyloidosis a patient has in order to provide the appropriate treatment.

The Center for Physician Education created this module so you will be able to identify and describe the different types amyloidosis, explain the commonality of amyloidosis, identify which organ amyloidosis affect and how it affects them. You will be able to describe the pertinenet physical examination and cardiac findings in AL amyloidosis and describe the definitive tests used to diagnose AL amyloidosis.  To access this video go to



For more information, and resources, for Amyloidosis please go to

Re-framing Pharmacogenomics in a Public Health Context - Fairbanks Center for Medical Ethics Presentation

Ethical Considerations Surrounding Parental Vaccination Refusals - Fairbanks Ethics Lecture Series

Contact Us


    The Office of Clinical Education

  • Phone: (317) 962-5048

  • Email: